HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells.

Abstract
tert-Butylhydroquinone (BHQ), an antioxidant used as a food additive, exhibits an anticancer effect at low doses, but is carcinogenic in rodents at high doses. BHQ is metabolized into cytotoxic tert-butylquinone (TBQ), which is further converted to 6-tert-butyl-2,3-epoxy-4-hydroxy-5-cyclohexen-1-one (TBEH) through 6-tert-butyl-2,3-epoxy-4-benzoquinone (TBE). Both TBQ and TBE are cytotoxic, but their toxic mechanisms have not been fully characterized. In this study, we have investigated the toxic mechanisms of TBQ and TBE, and the defense system against the two p-quinones using lung cancer A549 cells. TBQ and TBE, but not BHQ and TBEH, showed cytotoxicity to A549 cells. Neither caspase-3 activation nor an increase in the expression of endoplasmic reticulum stress-associating target genes was observed. TBQ and TBE reacted with reduced glutathione, and significantly decreased the glutathione level in A549 cells, suggesting that the cytotoxicity of the p-quinones is caused by their high electrophilicity reacting with biomolecules. The A549 cells treated with the p-quinones also showed increased levels of autophagic vacuoles and LC3-II protein, which are specific autophagy markers. An autophagy inhibitor, 3-methyladenine (3MA), decreased the LC3-II production by the p-quinones, but enhanced the cytotoxicity induced by TBQ and TBE, suggesting that autophagy contributes to alleviating the p-quinone-triggered cytotoxicity. In addition, the TBE-induced cytotoxicity and autophagy activation in the cells were significantly suppressed by overexpression of aldo-keto reductase (AKR)1B10 that efficiently reduces TBE into TBEH, and were augmented by pretreatment with a potent AKR1B10 inhibitor, C1. The effects of 3MA and C1 on the TBE-induced cytotoxicity were additive. The data provides evidence for the first time that autophagy and AKR1B10 contribute to the defense system against the cytotoxicity caused by the electrophilic p-quinone metabolites of BHQ.
AuthorsSatoshi Endo, Ayako Nishiyama, Miho Suyama, Mayuko Takemura, Midori Soda, Huayue Chen, Kazuo Tajima, Ossama El-Kabbani, Yasuo Bunai, Akira Hara, Toshiyuki Matsunaga, Akira Ikari
JournalChemico-biological interactions (Chem Biol Interact) Vol. 234 Pg. 282-9 (Jun 05 2015) ISSN: 1872-7786 [Electronic] Ireland
PMID25289770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antioxidants
  • Benzoquinones
  • Hydroquinones
  • MAP1LC3A protein, human
  • Microtubule-Associated Proteins
  • 6-tert-butyl-2,3-epoxy-1,4-benzoquinone
  • quinone
  • 3-methyladenine
  • 2-tert-butylhydroquinone
  • AKR1B10 protein, human
  • Aldo-Keto Reductases
  • Aldehyde Reductase
  • Caspase 3
  • 2-tert-butyl-4-quinone
  • Glutathione
  • Adenine
Topics
  • Adenine (analogs & derivatives, pharmacology)
  • Aldehyde Reductase (genetics)
  • Aldo-Keto Reductases
  • Antioxidants (pharmacology)
  • Autophagy (genetics)
  • Benzoquinones (pharmacology)
  • Caspase 3 (genetics)
  • Cell Line, Tumor
  • Endoplasmic Reticulum (drug effects, genetics)
  • Glutathione (genetics)
  • Humans
  • Hydroquinones (pharmacology)
  • Lung Neoplasms (genetics)
  • Microtubule-Associated Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: